Media Mentions
2008
McDermott Will & Emery's Intellectual Property, Media & Technology Department was featured in IP Law360 on September 3. The article discusses the Intellectual Property Department, highlights some of the Firm's recent accomplishments and includes comments on some of the trends of IP. To view the entire article click here.
Terrence P. McMahon, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech, Patent Prosecution
On September 1 McDermott Will & Emery was profiled in The National Law Journal in an article titled, "McDermott's IP litigation team tallies jury trial wins." The article highlights McDermott's intellectual property litigation team including, Sarah Columbia, Joel Freed, Terry McMahon and Fay Morisseau, "rack[ing] up five mainly favorable jury trial verdicts in the course of five months in five different federal districts." The article notes, "...[I]t's an unusual string of results in an era when most cases don't even go to trial. The trials took place in federal courts in California, Delaware, Massachusetts, Texas and Wisconsin." Mr. Morisseau commented, "What we do better than anyone else in the country is we work across offices to pull the people with the skills needed and we are not hesitant to take a case to trial."
Sarah Chapin Columbia, Joel M. Freed, Terrence P. McMahon, Fay Morisseau, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
Terrence P. McMahon was quoted in the August 4 issue of The Recorder in an article regarding the U.S. Court of Appeals for the Federal Circuit's removal of U.S. District Judge Manuel Real from a patent infringement case. The Federal Circuit threw out Microsoft's 2006 win over Research Corporation Technologies (RCT), reversing Real's decision declaring RCT's patents unenforceable and tossing his orders that found the patents invalid and non-infringing. Mr. McMahon, who represented RCT before Judge Real, said he was happy to get a new judge on the case. "It was clear that he had a point of view and we disagreed with it – we tried the case and he cut us off at every pass. I've never had something like this in my whole career, and I hope I never do again," he said. "A new day has dawned. Everything that Judge Real did has been erased," he added.
Terrence P. McMahon, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
John R. Fuisz was quoted in the July 25 issue of IP Law360 in an article regarding the U.S. Patent and Trademark Office's warning about certain outsourcing practices including shipping data about an invention to another country for the purpose of preparing a U.S. patent application. Mr. Fuisz noted that patent applicants who do not abide by export laws and do not obtain the necessary clearances to outsource work may run into trouble in patent litigation down the road. "It can affect you in litigation. A district court doesn't have discretion not to hold the patent unenforceable," he said. "Just because the Internet exists, doesn't mean you can send patent applications around the world without paying attention to U.S. laws," Mr. Fuisz added.
John R. Fuisz, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech, Patent Prosecution
Paul Devinsky was quoted in the June 2008 issue of Inside Counsel in an article regarding the Federal Circuit's ruling in the case of David Barstow, a former employee of Schlumberger Technology Corporation who invented software while employed by the company. The court ruled that Schlumberger must prove that the patents at issue were related to or suggested by David's work for the company in order to gain ownership. "This was a huge signal to the district court judge that unless Schlumberger did something to make people think the inventions belonged to the company, the inventions belong to David Barstow," Mr. Devinsky said. As for whether companies should create internal review processes for determining whether they own employees' inventions, Mr. Devinsky noted that "most companies will not be happy to make a decision on whether or not they own something."
Paul Devinsky, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
Joel M. Freed was recognized in the 2008 issue of the Legal Times Almanac of Leading Lawyers. Mr. Freed was noted for his work in Intergraph Corp. v. Intel Corp., a case that struck the balance between intellectual property and antitrust in favor of intellectual property.
Joel M. Freed, Antitrust - IP, Media & Tech, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
Sarah Chapin Columbia was quoted in the June 6 issue of the Boston Business Journal in an article regarding the decreasing number of IP-related lawsuits going to trial in Massachusetts due to the belief that other venues offer speedier resolution. Some Massachusetts companies are opting to file in other federal courts where, for example, the court may have a record of being plaintiff-friendly or may offer a faster trial. "There's a lot of venue shopping going on," Ms. Columbia said.
Sarah Chapin Columbia, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
Paul Devinsky was quoted in the May 1 issue of CFO Magazine in an article regarding whether business-process methods should be protected by patent law. On May 8, the U.S. Court of Appeals for the Federal Circuit will hear In Re Bernard L. Bilski and Rand A. Warsaw and may deliver a decision that clarifies where to draw the line on patentable subject matter. Mr. Devinsky noted, however, that if Bilski doesn’t decide the matter, the business-method patent issue will be "all teed up for the Supreme Court."
Paul Devinsky, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech, Patent Prosecution
Astrid R. Spain was quoted in the April 29 issue of The Daily Transcript in an article regarding patent reform bills currently before Congress. Ms. Spain commented on the bills' controversial provision which requires reasonable royalties or lost profits in infringement lawsuits to only be applied to the economic value of the specific contribution the patent makes to the product. The change, "bogs down the judges and juries with massive data and expert testimony on figuring out what exactly is the apportionment, which would make lawsuits more expensive and increase damages," Ms. Spain said. Regarding hopes that the bills will pass, Ms. Spain noted, "Clearly we have a lot of different industries with divergent interests, and our Congress represents all of these businesses and needs to strike a balance to encourage American innovation."
Astrid R. Spain, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
2007
William Gaede was quoted in an October 23 article published by IP Law360 regarding a federal jury's ruling that Amgen Inc.'s patents were infringed by Roche Holding AG's generic drug Mircera. Mr. Gaede represented Amgen in the case along with others from McDermott. "We're thrilled with it…It's a terrific victory for Amgen," Mr. Gaede commented.
William Gaede, Intellectual Property, Media & Technology, Life Sciences & Medical Device Litigation, Life Sciences & Medical Devices, Life Sciences - IP, Litigation - IP, Media & Tech
Paul Devinsky was quoted in a September 11 article by Technology Daily regarding patent holding firm NTP's decision to sue several of the nation's largest wireless carriers for alleged patent infringement. Mr. Devinsky's prediction is that the defendants would move for an immediate stay pending conclusion of the re-examination and that the stay would be granted. He suggested that NTP may be concerned about pending patent litigation on Capitol Hill and that NTP "is seeking to be certain their damage claim is calculated under the current statute."
Paul Devinsky, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech, Patent Prosecution
Vera M. Elson was quoted in the July 20 issue of The Recorder in an article regarding law firms expanding their practice in the area of accelerated patent cases before the International Trade Commission. Ms. Elson explains that it is very difficult for firms to enter the practice of accelerated patent cases. "It's the kind of thing where you can't make a halfhearted effort....It's a hard thing to dabble in," Ms. Elson said.
Vera M. Elson, Intellectual Property, Media & Technology, International Trade Commission, Litigation - IP, Media & Tech
Mark Wine was quoted on May 15 in IP Law360 in regards to Microsoft’s move to seek patent royalties from open source distributors and users. “It was a surprise last Fall when they signed [an agreement] with Novell….You had to figure at some point they’d engage in some kind of marketing attempt that would steer people towards their licensed Linux provider…. This may simply be the beginning of that effort,” commented Mr. Wine. He continued, “There are several big contracts up for consideration…. By threatening users and distributors with a lawsuit, they could [be using] this announcement to steer customers towards licensed software instead of unlicensed Linux providers, such as Red Hat.”
, Intellectual Property, Media & Technology, Licensing, Litigation - IP, Media & Tech, Patent Prosecution
Mark P. Wine was quoted in a May 15 article published by IDG News Service regarding Microsoft’s move to seek patent royalties from open source distributors and users in an attempt to use legal threats to deflect attention from company problems. Mr. Wine agreed that Microsoft is hoping companies will pay without a fight rather than engage them in a legal battle. He also said Microsoft may be trying to drive open source software users to migrate to its products. "I think it's as much a marketing move as anything else," he said. "If you're really serious, you sit down and have a discussion, and you tell [open-source users] which patents, or you sue them." This article appeared in MacWorld and Computer World.
, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech, Trademark/Brand Protection & Enforcement
Mark Wine was quoted in IP Law360 on April 20 in regard to Hewlett-Packard's filing of a patent infringement suit against Acer Inc. and its American subsidiary, Acer America Corp. "It's a compliment of sorts to Acer, which has made up a lot of ground and is beginning to challenge its competitors," commented Mr. Wine. He continued by commenting that, "And when a competitor starts nipping at your heels you start to look at IP more critically." This article also appeared on March 28.
, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
Stephen Becker was quoted by Reuters on February 23 regarding the $1.52 billion patent verdict against Microsoft Corp. "This is one that impacts on everyone that has an MPS," commented Mr. Becker. "It's not only impacting on makers of esoteric technology."
Stephen A. Becker PC, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
David Gay was quoted in the Contra Costa Times on February 22 in an article on the ruling by the USPTO against Genentech in the re-examination of its patent that generates an estimated $300 million a year in royalties from companies using the technology to make cancer and rheumatoid arthritis treatments. "An earlier patent on the technology expired last year, and companies paying royalties expected to be able to stop," said Mr. Gay. "That's the idea that's upsetting people, and they are hoping the patent would go away," he said. "Somebody got heated up enough to say, 'I'm going to stop this,' and they filed the re-exam request."
David A. Gay Ph.D., Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
Astrid Spain was quoted in the East Bay Business Times on February 21 in an article about the rejection by the USPTO of Genentech's claims to a lucrative patent covering methods for making monoclonal antibodies. "If the decision holds up, it would mean there was clearly some art that was missed in the initial examination that would create a substantial new question of patentability," said Ms. Spain. "In general, Genentech is known to have a very sound patent strategy and high-level patent prosecution. That something was missed - a piece of prior art - is surprising, particularly for a patent that is of such importance."
Astrid R. Spain, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
Terrence P. McMahon and William Gaede were featured in the February 2007 issue of IP Law & Business in a two-page article, "Trial Tips: In the race to develop a new drug for juvenile growth disorder, did Insmed rely on Genentech's patents?" This article discusses the closely watched biotechnology case, Genentech Inc. et al. v. Insmed Incorporated et al., the history of the patent battle for co-plaintiffs Genentech and Tercica, and the trial strategies employed by the McDermott team for Firm client Tercica.
William Gaede, Terrence P. McMahon, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech, Trial
2006
Terrence P. McMahon was profiled in the November issue of American Lawyer in regard to his representation of Creative Technology, Ltd. in its lawsuit against Apple Computer, Inc. The article, "Top of the Docket: McDermott's Jury Master," was part of the Big Suits column which also featured the litigation.
Terrence P. McMahon, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
Astrid Spain was quoted in the October 5 edition of The Baltimore Sun in an article discussing the arguments presented before the U.S. Supreme Court in the MedImmune Inc. v. Genentech Inc. Ms. Spain commented, "Licensing relationships are such an integral part of everyday business, that I think there's a lot of interest from the corporate world in this case." She was also quoted in an interview with Bloomberg News. A ruling in MedImmune's favor would put companies seeking a license "in a totally different position in that power balance" in negotiations.
Astrid R. Spain, Intellectual Property, Media & Technology, Life Sciences & Medical Devices, Life Sciences - IP, Litigation - IP, Media & Tech
On June 22, Marc E. Brown was quoted in InformationWeek in the article, "Supreme Court Sidesteps Deciding Key Patent Case." The article discussed the Court’s ruling on a patent infringement case that had the potential to invalidate business-method patents. Regarding the Court’s decision to dismiss an appeal by Laboratory Corporation of America because it addressed issues not dealt with by lower courts, Mr. Brown suggested a decision could have removed one of the clouds hanging over business method payments. "This case had the potential of seriously disrupting the status quo, but the Court's inaction signaled that a change is no longer immediately on the horizon as the Federal Circuit has been very pro business-method patents, so contrary to a decision by the Supreme Court, the right to a business-method patent is pretty secure."
Marc E. Brown, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
David Beckwith was quoted in the May 19 issue of the San Diego Daily Transcript in an article discussing the recent decision by the U.S. Supreme Court in eBay v. MercExchange: "The District Court really put a lot of focus on the fact that MercExchange was willing to license and wasn't practicing an invention themselves."
David M. Beckwith, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
Paul Devinsky was quoted by Globe and Mail on April 11 regarding China Unicom Ltd.’s. new push mail service called "RedBerry" and its possible trademark infringement of the "BlackBerry" name. Mr. Devinsky commented that the consumers' likelihood of confusion would be strong enough for Research in Motion (RIM) to have a persuasive case. Mr. Devinsky also said "RIM's position would probably be enhanced in a Chinese court if China Mobile joined any action against RedBerry. Ultimately, any legal fight would hinge on who registered the trademark and service mark for BlackBerry first in China…"
Paul Devinsky, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
Paul Devinsky was quoted by the National Journal's Technology Daily on January 23 in the article, "Supreme Court Declines Review of Blackberry Dispute." Mr. Devinksy commented, "Basically, RIM has to figure out a way of either getting [U.S. District] Judge [James] Spencer to issue his injunction, and put it on stay pending Patent and Trademark Office developments, or they're going to have to settle..."
Paul Devinsky, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
Dennis Mondolino, Lisa Ferri, Michael Hurley and Jason Lief were mentioned in the 1/2006 issue of Juve Rechtsmarkt as new IP lawyers based in our New York office.
Lisa M. Ferri, Michael F. Hurley, Jason A. Lief, Dennis J. Mondolino, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
2005
An article entitled "Express Route" from the August 2005 issue of IP Law & Business features the success that Tracey Thomas, American Express's Chief IP Counsel, has had in developing American Express's IP program. The article notes that in the five years that Tracey has been American Express's Chief IP Counsel, he has increased the number of patents in American Express's patent portfolio from 10 to 50, launched a patent licensing program that has generated millions of dollars in revenue and successfully defended the company in several patent infringement cases. McDermott is mentioned as American Express's patent litigation counsel.
Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
Mauricio Flores was quoted in The Wall Street Journal on June 14 in regard to the U.S. Supreme Court's decision, vacated and remanded, in Merck KGaA v. Integra LifeSciences (03-1237), in which Mauricio argued before the Court on behalf of Integra. Mauricio was also quoted in the Associated Press, Law.com, Washington Post,Los Angeles Times, The New York Times, San Diego Union-Tribune and San Francisco Daily Journal.
, Intellectual Property, Media & Technology, Life Sciences & Medical Devices, Life Sciences - IP, Litigation - IP, Media & Tech, Trial
Mauricio Flores was quoted in the June 14 issue of the ABA Journal regarding the U.S. Supreme Court's decision in Merck KGaA v. Integra LifeSciences (03-1237). Mr. Flores said the running "won't have a dramatic impact" on drug companies' research practices.
, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
Cathryn Campbell and Mauricio Flores were quoted in the June 13 issue of the San Diego Daily Transcript in regard to the U.S. Supreme Court's decision, in Merck KGaA v. Integra LifeSciences (03-1237). "We would've been disappointed if they came out with a bright line that said everything in pre-clinical research is exempt, and they didn't do that," commented Dr. Campbell. "In fact the Supreme Court in effect adopted the interpretation of the law that Mauricio Flores and his team proposed at the trial." Mr. Flores commented: "This issue has to be approached on a case-by-case basis."
, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
Mauricio Flores was quoted in the June issue of Corporate Legal Times in an article reporting on Merck KGaA v. Integra LifeSciences, et al. which was argued before the U.S. Supreme Court this spring. Integra argued that Scripps was conducting research for a lot of commercial reasons unrelated to a FDA application. "We think that the evidence show that what was going on at Scripps was not FDA related, that they were just trying to come up with some FDA justification after the fact," commented Mr. Flores, who argued the case before the Supreme Court on behalf of Integra. "They were doing it to generally strengthen the scientific premise of Merck's drug program. The premise is that if you inhibit a particular receptor with anything, whether its' an RGD peptide or something completely different, you can inhibit the growth of blood vessels. So that's a non-FDA related purpose."
, Intellectual Property, Media & Technology, Life Sciences & Medical Devices, Life Sciences - IP, Litigation - IP, Media & Tech
Mauricio Flores was quoted in the April 21 issue of the San Diego Union-Tribune in regard to representing Integra LifeSciences before the U.S. Supreme Court.
, Intellectual Property, Media & Technology, Life Sciences & Medical Devices, Life Sciences - IP, Litigation - IP, Media & Tech
Cathryn Campbell was quoted in the New York Times on April 19 and the Boston Globe and Los Angeles Times on April 20 regarding our representation of Integra LifeSciences in Merck RGaA v. Integra Life Sciences before the U.S. Supreme Court.
, Intellectual Property, Media & Technology, Life Sciences & Medical Devices, Life Sciences - IP, Litigation - IP, Media & Tech
Mauricio Flores was quoted, "Justices to Review Patent Safe Harbor," an article that appeared in the April 11 issue of The National Law Journal regarding Merck KGaA v. Integra LifeSciences. Mr. Flores commented on the case which is scheduled to be argued before the U.S. Supreme Court on April 20. The article examined the Merck case and questioned "how far down the chain of research and experimentation into new drugs does a federal safe harbor statute reach to protect drug manufacturers from liability for patent infringement."
, Intellectual Property, Media & Technology, Life Sciences & Medical Devices, Life Sciences - IP, Litigation - IP, Media & Tech
Cathryn Campbell and Mauricio Flores were quoted in the April 1 issue of San Diego's The Daily Transcript in the article, "Patent disputed leads local law firm to the U.S. Supreme Court." Mr. Flores will present the case for Integra LifeSciences, which is charging Merck KGaA with patent infringement. Mr. Flores states, "it's always exciting to argue something in front of the highest court in the land, especially something this important." Dr. Campbell notes that "this is a very important case and it's been recognized as such," and "everyone from big pharmaceutical companies and biotech firms to bar associations and law professors will be watching the proceedings."
, Intellectual Property, Media & Technology, Life Sciences & Medical Devices, Life Sciences - IP, Litigation - IP, Media & Tech
A profile of Seth Greenstein and his fight for Static Control Components Inc. under the Digital Millennium Copyright Act appeared in the January 2005 issue of IP Law & Business. The profile also ran in the January 31 issue of Legal Times.
, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
2004
Chambers USA 2004, states clients were quick to commend [the IP group] as one that is "focused on cost control, easy to work with and understanding of all the technology issues." The firm dedicates a huge amount of resources to the IP arena, with over 40 attorneys in the Washington, D.C. office covering patent litigation, for example. Peers and clients alike praised its work at the ITC as "an example of real expertise." Operating on a cross-office basis, the firm uses the expertise of colleagues in California for its hi-tech clients.
Intellectual Property, Media & Technology, International Trade Commission, Litigation - IP, Media & Tech
Terry McMahon was recognized as one of the "Best in the West," in an article published in the August 2004 issue of California Lawyer. The article which featured California's leading business lawyers in a range of practice areas was a result of a collaboration between California Lawyer and Chambers & Partners, the London-based publishing company that annually ranks lawyers by practice as a result of in-depth interviews with clients and peers. Mr. McMahon was one of three lawyers recognized in the area of IP.
Terrence P. McMahon, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
Ray Lupo and Paul Devinsky were quoted in the National Law Journal on February 9 on the Federal Circuit's shifting views on how to define the words or claims that describe the scope of a patent. In Texas Digital Systems it ruled that dictionary definitions are the first source for construing the meaning of a claim. "The court backed off on Texas Digital," commented Mr. Lupo. It has tried to harmonize Texas digital with a 1996 decision (Vitronics) where it established tools courts should use to evaluate claim constructions. In the Vitronics decision specifications in the patent were considered the most important tool. "In Judge Richard Linn's view, you go to the dictionary first, and only if the specification is inconsistent with the dictionary need it be considered," commented Mr. Devinsky. "In Judge Michel's view, the specification has to be consulted in every claim construction."
Paul Devinsky, Raphael V. Lupo, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
Seth Greenstein and Melise Blakeslee gave The Deal an insiders view on the Lexmark vs. Static Control Components (SCC) case, as members of the SCC defense team, in the publication’s January 26 issue. The article discussed this precedent setting case and some of the trickiest issues of IP law in the digital age as computer manufacturer Lexmark sued SCC, a maker of parts for the remanufacture of toner cartridges, for copyright infringement.
Melise R. Blakeslee, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
Matthew Weil was quoted on Newsday.com January 9 regarding a trademark infringement case between KP Permanent Make-up Inc. and Lasting Impressions. The article explained that the two companies, who both sell bottled pigment to salons for the purpose of tattooing permanent makeup, are fighting over the use of "micro color" as a trademark. Mr. Weil commented that the Supreme Court will decide whether there can be infringement by one company's use of the word "micro color" when another company has that term as part of its trademark-protected logo.
Matthew F. Weil, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech, Trademark/Brand Protection & Enforcement
2003
Stephen Becker was quoted in the Wall Street and Technology on October 1 regarding Reuters lawsuit against Bloomberg. Mr. Becker stated that "If Reuters prevails in this litigation there may be retroactive damages, future payments, or even an order prohibiting Bloomberg from using the patented technologies". Mr. Becker continued by stating, "During litigation there’s a huge war chest available to redo whatever research the patent examiner has already done." Mr. Becker notes if the precedent prevails, the most likely outcome would be either payment or settlement.
Stephen A. Becker PC, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
McDermott Will & Emery was mentioned in the August 2003 issue of Intellectual Property Today for successfully representing Burnham Institute and Integra LifeSciences, by obtaining a significant victory related to patent infringement in the context of biomedical research.
Intellectual Property, Media & Technology, Life Sciences & Medical Devices, Life Sciences - IP, Litigation - IP, Media & Tech
McDermott Will & Emery's Intellectual Property Department was recognized in IP Law & Business' (formerly IP Worldwide) third annual report on who's winning all the business, "Swords & Shields," published in its May 2003 issue. McDermott Will & Emery ranked as one of the Top 10 defense firms in the U.S. and was 11th among the top 41 law firms to be recognized as counsel hired by plaintiffs and defendants involved in patent cases filed in 2002. The Firm's IP Department filed a total of 30 patent cases on behalf of Firm clients and defended 22 cases in 2002.
Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
McDermott Will & Emery was mentioned in the March issue of Intellectual Property Today in regard to the Firm's IP victory for CIBA Vision in the U.S. Court of Appeals for the Federal Circuit and the victorious multi-patent litigation settlement on behalf of Three Rivers Pharmaceutical.
Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
Terry McMahon was listed as one of California's top intellectual property lawyers in the cover story, "Think Big," which ran in the Daily Journal EXTRA on February 24. Mr. McMahon, who was among 25 IP lawyers recognized, was noted for both his success in the courtroom on big ticket IP litigation and his efforts to help build the Firm's IP practice. Click here to see an excerpt.
Terrence P. McMahon, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
McDermott Will & Emery was mentioned as counsel for Wesley Jessen in its patent infringement case against Bausch & Lomb's PureVision contract lenses. On February 20, the Asia Intelligence reported on the Federal Circuit Court's decision to uphold the lower court decision which prevents the sale of PureVision contact lenses in the United States.
Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
Ray Lupo was quoted extensively on February 11 in a IDG News Service wire, which appeared as an article on February 11 in InfoWorld. The article reported on the SCO Group and the Linux legal war. Mr. Lupo commented that a weak economy can open the doors for revenue-starved vendors to file intellectual property claims.
Raphael V. Lupo, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
McDermott Will & Emery was mentioned in the January issue of Intellectual Property Today in regard to the success of the Firm's IP litigation team representing Roxio, Inc. in Caffarelli v. Adaptec.
Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
2002
McDermott's patent victory for CIBA Vision, identified as a "high-stakes patent suit" was mentioned in the July 8 issue of Legal Times. The Firm's legal team included partners Ken Cage, Ray Lupo, Tom Steindler and Chuck Work, and associates Pascale Bishop and Dan Bucca.
Intellectual Property, Media & Technology, Litigation - IP, Media & Tech, Trial
The Firm's Intellectual Property Practice on behalf of client Medtronic in Cordis Corp. v. Medtronic AVE was named the "Defense Win of the Month" in the April 22 issue of The National Law Journal. On December 21, 2000, a jury awarded Cordis Corp. $271.1 million in damages in a consolidated civil action against Medtronic AVE. Following this adverse verdict, Medtronic asked McDermott Will & Emery to step in and handle the post-trial briefs. MW&E's legal team led by Ray Lupo and included Natalia Blinkova. Mr. Lupo argued the motion and successfully convinced Chief Judge Sue Robinson of the District Court of Delaware that Medtronic AVE had not infringed the Palmaz-Schatz patents, resulting in the overturning of the jury's verdict and damages award.
Intellectual Property, Media & Technology, Litigation - IP, Media & Tech, Trial
Terry McMahon and the Firm's West Coast IP Group were profiled on the front page of the March 14 issue of the San Francisco Daily Journal. Mr. McMahon, whose continued success in the courtroom is expounded upon by multiple third parties, was called the "Go-To Guy in the Valley for Intellectual Property." The article highlights McDermott's IP practice by mentioning the Firm's recent successes, client-base and recruitment of leading lawyers.
Terrence P. McMahon, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech, Trial
Ray Lupo was mentioned as counsel for the appellants in Aptix Corp., et. al. v. Quickturn Design Systems Inc., which was ranked by in the March 4 issue of Legal Times as one of the top 10 patent decisions from the U.S. Court of Appeals for the Federal Circuit from October 2001 through January 2002.
Raphael V. Lupo, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech, Trial
McDermott Will & Emery was listed in the May 2 issue of Corporate Counsel as one of top law firms that global companies call when they need U.S. patent litigation and patent prosecution.
Intellectual Property, Media & Technology, Litigation - IP, Media & Tech, Patent Prosecution
Terry McMahon was profiled in "A New Meaning for 'Win-tel'" in the March issue of American Lawyer. Included with the Big Suits report on the Intel v. Broadcom case, the article focused on Terry's 3-0 patent litigation record against Intel.
Terrence P. McMahon, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech, Trial
Intellectual Property Practice was recommended as one of "Six Strong IP Law Firms" in an article published in the March issue of Washington Business Forward. The article, "Smart Moves on Intellectual Property," lists three IP boutique firms and three general practice law firms. The article addresses the benefits and sales pitch of general practice firms like McDermott arguing they can offer clients a broader range of services. Ray Lupo agreed commenting, "Patent and IP boutiques don't have some of the broader range of expertise that comes up in patent cases. We sell that we have both." McDermott was also mentioned as having 140 IP lawyers, as well as currently handling 60 patent infringement cases in federal courts and at the International Trade Commission.
Intellectual Property, Media & Technology, Litigation - IP, Media & Tech, Patent Prosecution
Terry McMahon was profiled as one of the "biggest ripples in the lateral pond" (2001) in the February 2002 issue of American Lawyer.
Terrence P. McMahon, Intellectual Property, Media & Technology, Litigation - IP, Media & Tech
